A detailed history of Hsbc Holdings PLC transactions in Cerus Corp stock. As of the latest transaction made, Hsbc Holdings PLC holds 118,158 shares of CERS stock, worth $206,776. This represents 0.0% of its overall portfolio holdings.

Number of Shares
118,158
Previous 135,568 12.84%
Holding current value
$206,776
Previous $256,000 19.14%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$1.62 - $2.04 $28,204 - $35,516
-17,410 Reduced 12.84%
118,158 $207,000
Q1 2024

May 15, 2024

BUY
$1.66 - $2.42 $65,596 - $95,628
39,516 Added 41.14%
135,568 $256,000
Q4 2023

Feb 12, 2024

BUY
$1.25 - $2.35 $193 - $364
155 Added 0.16%
96,052 $207,000
Q3 2023

Nov 13, 2023

BUY
$1.5 - $3.07 $46,914 - $96,017
31,276 Added 48.4%
95,897 $155,000
Q2 2023

Aug 11, 2023

SELL
$1.79 - $2.9 $3,501 - $5,672
-1,956 Reduced 2.94%
64,621 $158,000
Q1 2023

May 15, 2023

BUY
$2.65 - $3.81 $3,190 - $4,587
1,204 Added 1.84%
66,577 $197,000
Q4 2022

Feb 14, 2023

BUY
$3.38 - $4.22 $11,786 - $14,715
3,487 Added 5.63%
65,373 $238,000
Q3 2022

Nov 14, 2022

BUY
$3.43 - $5.83 $3,416 - $5,806
996 Added 1.64%
61,886 $227,000
Q4 2021

Feb 11, 2022

SELL
$5.97 - $7.93 $66,028 - $87,705
-11,060 Reduced 15.37%
60,890 $414,000
Q3 2021

Nov 12, 2021

BUY
$4.79 - $6.68 $160,378 - $223,659
33,482 Added 87.04%
71,950 $445,000
Q1 2021

May 14, 2021

SELL
$5.68 - $7.87 $23,952 - $33,187
-4,217 Reduced 9.88%
38,468 $231,000
Q4 2020

Feb 12, 2021

SELL
$5.25 - $8.56 $224,941 - $366,761
-42,846 Reduced 50.09%
42,685 $295,000
Q3 2020

Nov 12, 2020

BUY
$5.78 - $7.47 $145,644 - $188,229
25,198 Added 41.76%
85,531 $542,000
Q2 2020

Aug 14, 2020

BUY
$4.5 - $7.02 $53,815 - $83,952
11,959 Added 24.72%
60,333 $398,000
Q1 2020

May 15, 2020

BUY
$2.87 - $5.49 $33,642 - $64,353
11,722 Added 31.98%
48,374 $219,000
Q4 2019

Feb 14, 2020

BUY
$3.84 - $4.86 $140,743 - $178,128
36,652 New
36,652 $154,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $310M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.